Dario Giugliano

45.7k total citations · 13 hit papers
457 papers, 32.6k citations indexed

About

Dario Giugliano is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Molecular Biology. According to data from OpenAlex, Dario Giugliano has authored 457 papers receiving a total of 32.6k indexed citations (citations by other indexed papers that have themselves been cited), including 260 papers in Endocrinology, Diabetes and Metabolism, 110 papers in Physiology and 101 papers in Molecular Biology. Recurrent topics in Dario Giugliano's work include Diabetes Treatment and Management (120 papers), Diabetes Management and Research (99 papers) and Metabolism, Diabetes, and Cancer (67 papers). Dario Giugliano is often cited by papers focused on Diabetes Treatment and Management (120 papers), Diabetes Management and Research (99 papers) and Metabolism, Diabetes, and Cancer (67 papers). Dario Giugliano collaborates with scholars based in Italy, United Kingdom and Belgium. Dario Giugliano's co-authors include Katherine Esposito, Antonio Ceriello, Raffaele Marfella, Giuseppe Paolisso, Maria Ida Maiorino, Giovanni Giugliano, Giuseppe Bellastella, Francesco Nappo, Paolo Chiodini and Francesco Giugliano and has published in prestigious journals such as The Lancet, JAMA and Circulation.

In The Last Decade

Dario Giugliano

450 papers receiving 31.3k citations

Hit Papers

Oxidative Stress and Diabetic Vascular Complications 1996 2026 2006 2016 1996 2002 2004 2003 2008 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Oxidative Stress and Diabetic Vascular Complications
    1996 1.6k citations Dario Giugliano, Antonio Ceriello et al. Diabetes Care profile →
  2. Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in Humans
    2002 1.6k citations Katherine Esposito, Francesco Giugliano et al. Circulation profile →
  3. Effect of a Mediterranean-Style Diet on Endothelial Dysfunction and Markers of Vascular Inflammation in the Metabolic Syndrome
    2004 1.6k citations Katherine Esposito, Miryam Ciotola et al. profile →
  4. Effect of Weight Loss and Lifestyle Changes on Vascular Inflammatory Markers in Obese Women
    2003 1.2k citations Katherine Esposito, Alessandro Pontillo et al. profile →
  5. Oscillating Glucose Is More Deleterious to Endothelial Function and Oxidative Stress Than Mean Glucose in Normal and Type 2 Diabetic Patients
    2008 987 citations Antonio Ceriello, Katherine Esposito et al. profile →
  6. Metabolic Syndrome and Risk of Cancer
    2012 914 citations Katherine Esposito, Paolo Chiodini et al. Diabetes Care profile →
  7. The Effect of Mediterranean Diet on Metabolic Syndrome and its Components
    2011 777 citations Katherine Esposito, Dario Giugliano et al. profile →
  8. Reduction of Inflammatory Cytokine Concentrations and Improvement of Endothelial Functions in Obese Women After Weight Loss Over One Year
    2002 775 citations Katherine Esposito, Dario Giugliano et al. Circulation profile →
  9. The Effects of Diet on Inflammation
    2006 638 citations Dario Giugliano, Antonio Ceriello et al. profile →
  10. Effect of Lifestyle Changes on Erectile Dysfunction in Obese Men
    2004 569 citations Katherine Esposito, Francesco Giugliano et al. profile →
  11. A journey into a Mediterranean diet and type 2 diabetes: a systematic review with meta-analyses
    2015 316 citations Katherine Esposito, Maria Ida Maiorino et al. profile →
  12. Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials
    2020 227 citations Maria Ida Maiorino, Antonietta Maio et al. Diabetes Care profile →
  13. The effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTs
    2022 101 citations Dario Giugliano, Miriam Longo et al. Cardiovascular Diabetology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dario Giugliano Italy 91 13.4k 8.7k 5.8k 5.2k 5.1k 457 32.6k
Katherine Esposito Italy 82 10.7k 0.8× 6.8k 0.8× 4.2k 0.7× 3.7k 0.7× 5.1k 1.0× 325 26.0k
Karen A. Donato United States 10 11.1k 0.8× 7.9k 0.9× 2.9k 0.5× 6.1k 1.2× 6.7k 1.3× 16 29.1k
K. G. M. M. Alberti United Kingdom 71 17.4k 1.3× 9.8k 1.1× 5.1k 0.9× 5.9k 1.1× 5.8k 1.1× 445 38.4k
K. G. M. M. Alberti United Kingdom 58 16.2k 1.2× 6.9k 0.8× 5.7k 1.0× 4.9k 0.9× 4.7k 0.9× 238 33.7k
Leo Niskanen Finland 78 9.4k 0.7× 4.6k 0.5× 3.2k 0.5× 4.5k 0.9× 2.2k 0.4× 347 22.9k
Matti Uusitupa Finland 90 13.4k 1.0× 12.0k 1.4× 6.9k 1.2× 4.6k 0.9× 6.5k 1.3× 483 37.7k
Juliana C.N. Chan Hong Kong 87 18.0k 1.3× 5.1k 0.6× 7.9k 1.4× 5.3k 1.0× 3.3k 0.6× 849 39.5k
Coen D.A. Stehouwer Netherlands 119 15.7k 1.2× 12.4k 1.4× 6.7k 1.1× 17.6k 3.4× 5.2k 1.0× 1.1k 57.4k
Per Björntorp Sweden 93 10.1k 0.8× 14.2k 1.6× 3.6k 0.6× 5.1k 1.0× 4.9k 1.0× 449 31.9k
A. Rudenski United Kingdom 15 10.6k 0.8× 8.5k 1.0× 5.2k 0.9× 4.8k 0.9× 3.9k 0.8× 27 28.4k

Countries citing papers authored by Dario Giugliano

Since Specialization
Citations

This map shows the geographic impact of Dario Giugliano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dario Giugliano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dario Giugliano more than expected).

Fields of papers citing papers by Dario Giugliano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dario Giugliano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dario Giugliano. The network helps show where Dario Giugliano may publish in the future.

Co-authorship network of co-authors of Dario Giugliano

This figure shows the co-authorship network connecting the top 25 collaborators of Dario Giugliano. A scholar is included among the top collaborators of Dario Giugliano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dario Giugliano. Dario Giugliano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maiorino, Maria Ida, Antonietta Maio, Paola Caruso, et al.. (2025). The therapeutic efficacy of continuous glucose monitoring in diabetes: an updated meta-analysis with meta-regression. Endocrine. 90(3). 1138–1148.
2.
Caruso, Paola, Miriam Longo, Antonietta Maio, et al.. (2025). Exploring Insulin Resistance in Adults With Type 1 Diabetes: The Role of the Estimated Glucose Disposal Rate and the Triglyceride Glucose Index. Diabetes/Metabolism Research and Reviews. 41(7). e70100–e70100.
3.
Caruso, Paola, Lorenzo Scappaticcio, Miriam Longo, et al.. (2025). Association of semaglutide with less limb events in people with type 2 diabetes and peripheral artery disease or foot ulcers: An observational study comparing matched cohorts. Diabetes Obesity and Metabolism. 27(10). 5506–5513. 2 indexed citations
4.
Giugliano, Dario, Katherine Esposito, & Luca De Nicola. (2024). Diabetic kidney disease: The fourth pharmacological pillar may be semaglutide. Diabetes Obesity and Metabolism. 26(11). 4813–4815. 1 indexed citations
5.
6.
Giugliano, Dario, Luca De Nicola, Maria Ida Maiorino, & Katherine Esposito. (2024). Semaglutide cuts kidney risk in obesity. Journal of Endocrinological Investigation. 48(2). 295–298. 1 indexed citations
7.
Giugliano, Dario, Miriam Longo, Lorenzo Scappaticcio, et al.. (2023). BEYOND 2 years: durability of metabolic benefits by simplification of complex insulin regimens in type 2 diabetes. Endocrine. 83(2). 399–404. 3 indexed citations
8.
Giugliano, Dario, Lorenzo Scappaticcio, Miriam Longo, et al.. (2021). GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes: an updated meta-analysis of eight CVOTs. Cardiovascular Diabetology. 20(1). 189–189. 171 indexed citations
9.
Giugliano, Dario, Miriam Longo, Lorenzo Scappaticcio, et al.. (2021). SGLT-2 inhibitors and cardiorenal outcomes in patients with or without type 2 diabetes: a meta-analysis of 11 CVOTs. Cardiovascular Diabetology. 20(1). 236–236. 74 indexed citations
10.
Fabrazzo, Michele, Giacomo Accardo, Daniela Espósito, et al.. (2020). Quality of life in Klinefelter patients on testosterone replacement therapy compared to healthy controls: an observational study on the impact of psychological distress, personality traits, and coping strategies. Journal of Endocrinological Investigation. 44(5). 1053–1063. 10 indexed citations
11.
Giugliano, Dario, Maria Ida Maiorino, Giuseppe Bellastella, et al.. (2019). GLP‐1 receptor agonists for prevention of cardiorenal outcomes in type 2 diabetes: An updated meta‐analysis including the REWIND and PIONEER 6 trials. Diabetes Obesity and Metabolism. 21(11). 2576–2580. 96 indexed citations
12.
Bellastella, Giuseppe, Mariangela Caputo, Maria Ida Maiorino, et al.. (2019). EMPATHY: A New Tool for Identifying the Most Suitable Thyroxine Formulation in Hypothyroid Patients. Thyroid. 29(7). 928–933. 9 indexed citations
13.
Giugliano, Dario, Maria Ida Maiorino, Miriam Longo, et al.. (2019). Type 2 diabetes and risk of heart failure: a systematic review and meta-analysis from cardiovascular outcome trials. Endocrine. 65(1). 15–24. 23 indexed citations
14.
Maiorino, Maria Ida, Giuseppe Bellastella, Dario Giugliano, & Katherine Esposito. (2018). From inflammation to sexual dysfunctions: a journey through diabetes, obesity, and metabolic syndrome. Journal of Endocrinological Investigation. 41(11). 1249–1258. 98 indexed citations
15.
Accardo, Giacomo, Giovanni Conzo, Daniela Espósito, et al.. (2017). Genetics of medullary thyroid cancer: An overview. International Journal of Surgery. 41. S2–S6. 80 indexed citations
16.
Esposito, Katherine, Paolo Chiodini, Annamaria Colao, Andrea Lenzi, & Dario Giugliano. (2012). Metabolic Syndrome and Risk of Cancer. Diabetes Care. 35(11). 2402–2411. 914 indexed citations breakdown →
17.
Esposito, Katherine, Miryam Ciotola, Maria Ida Maiorino, et al.. (2009). Hyperlipidemia and Sexual Function in Premenopausal Women. The Journal of Sexual Medicine. 6(6). 1696–1703. 47 indexed citations
18.
Ceriello, Antonio, Roberta Assaloni, Roberto Da Ros, et al.. (2005). Effect of Atorvastatin and Irbesartan, Alone and in Combination, on Postprandial Endothelial Dysfunction, Oxidative Stress, and Inflammation in Type 2 Diabetic Patients. Circulation. 111(19). 2518–2524. 238 indexed citations
19.
Ceriello, Antonio, Dario Giugliano, Pierre Russo, et al.. (1983). Glycosaminoglycans in human diabetes.. PubMed. 9(1). 32–4. 15 indexed citations
20.
Sgambato, S, et al.. (1978). Effect of calcitonin on glucose--stimulated insulin secretion in normal, obese and prediabetic subjects.. PubMed. 33(6). 256–62. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katherine Esposito Breakdown of academic impact, for papers by Karen A. Donato Breakdown of academic impact, for papers by K. G. M. M. Alberti Breakdown of academic impact, for papers by K. G. M. M. Alberti Breakdown of academic impact, for papers by Leo Niskanen Breakdown of academic impact, for papers by Matti Uusitupa Breakdown of academic impact, for papers by Juliana C.N. Chan Breakdown of academic impact, for papers by Coen D.A. Stehouwer Breakdown of academic impact, for papers by Per Björntorp Breakdown of academic impact, for papers by A. Rudenski
Rankless by CCL
2026